CASR and coronary artery disorder: A reduction in vascular endothelial injury, inflammatory reactions, and lipid deposition was observed using UPLC-Q-TOF-MS/MS, network pharmacology, lipidomics, and RT-qPCR, in the treatment of CHD with CASR.